Device
IRRISEPT
IRRISEPT is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
1(25%)
Results Posted
100%(2 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
66.7%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
recruiting125%
terminated125%
completed250%
Recent Activity
1 active trials
Showing 4 of 4
completednot_applicable
Outcomes of Irrisept Irrigation as an Adjunctive Treatment in the Management of Diabetic Foot Ulcers
NCT06024590
recruitingnot_applicable
Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)
NCT06339203
completednot_applicable
Retrospective Independent Safety Review of Closed Irrisept Study
NCT05359666
terminatednot_applicable
The Effect Of Wound Irrigation With Irrisept™ Delivery System On Abscess Healing In Patients Presenting To The Emergency Department
NCT01302548
Clinical Trials (4)
Showing 4 of 4 trials
NCT06024590Not Applicable
Outcomes of Irrisept Irrigation as an Adjunctive Treatment in the Management of Diabetic Foot Ulcers
NCT06339203Not Applicable
Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)
NCT05359666Not Applicable
Retrospective Independent Safety Review of Closed Irrisept Study
NCT01302548Not Applicable
The Effect Of Wound Irrigation With Irrisept™ Delivery System On Abscess Healing In Patients Presenting To The Emergency Department
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4